Efficacy of Alectinib in Patients with ALK-Positive NSCLC and Symptomatic or Large CNS Metastases

Authors:

Abstract
No abstract available
Funding Information
  • Genentech
  • Novartis
  • National Cancer Institute (R01CA164273)
  • Roche
  • Massachusetts General Hospital
  • Clovis Oncology
  • Pfizer

This publication has 19 references indexed in Scilit: